Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes: A ≥52-week randomized, double-blind study

OBJECTIVE: To evaluate the efficacy and long-term safety of linagliptin added to basal insulins in type 2 diabetes inadequately controlled on basal insulin with or without oral agents. RESEARCH DESIGN AND METHODS: A total of 1,261 patients (HbA(1c) ≥7.0% [53 mmol/mol] to ≤10.0% [86 mmol/mol]) on bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yki-Järvinen, Hannele, Rosenstock, Julio, Durán-Garcia, Santiago, Pinnetti, Sabine, Bhattacharya, Sudipta, Thiemann, Sandra, Patel, Sanjay, Woerle, Hans-Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836100/
https://www.ncbi.nlm.nih.gov/pubmed/24062327
http://dx.doi.org/10.2337/dc12-2718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836100/
https://www.ncbi.nlm.nih.gov/pubmed/24062327
http://dx.doi.org/10.2337/dc12-2718

Ejemplares similares